Lumanity Executive and Leadership Team

Andrew Dreyfus, the President & Chief Executive Officer at Lumanity, directs the overarching corporate strategy and long-term vision for the organization. By aligning medical, commercial, and regulatory affairs, Dreyfus ensures the firm delivers transformative outcomes for pharmaceutical and biotech partners. The President & Chief Executive Officer oversees the integration of real-world evidence into commercialization pathways, enabling clients to navigate complex global markets with precision. Through the management of 1,200+ experts, the President & Chief Executive Officer maintains a focus on accelerating access to medical advances. Andrew Dreyfus fosters a culture of incisive thinking, which allows the company to translate scientific data into actionable insights for providers and regulators. This leadership role involves constant engagement with the Board to optimize operational efficiency and market impact. Ultimately, the President & Chief Executive Officer secures the firm's position as a leader in the life sciences consulting sector.

John Howley, the President, Communications (US) at Lumanity, directs all strategic messaging and stakeholder engagement initiatives across North American markets. By translating complex scientific data into compelling product narratives, Howley ensures that pharmaceutical brands resonate with diverse audiences, including payers and providers. The President, Communications (US) oversees the development of integrated campaigns that support successful product launches and sustainable market positioning. This leadership role requires close collaboration with global teams to maintain consistency in brand messaging while addressing specific regional regulatory requirements. John Howley drives the creation of evidence-based content that demonstrates the value of medical products, directly impacting commercial success. By managing the communications division, the President, Communications (US) enables clients to navigate the competitive landscape with clarity and authority. This focus on narrative excellence supports the broader mission of accelerating patient access to critical medical innovations through effective, data-driven communication strategies.

Marissa Poli, the President at Lumanity, directs internal operational scaling and organizational development to support the firm's global growth. By optimizing cross-functional workflows, Poli ensures that the company maintains high standards of service delivery across its diverse portfolio of medical and commercial projects. The President oversees the alignment of internal resources with the needs of top-tier pharmaceutical clients, facilitating seamless execution of development strategies and payer submissions. This leadership role involves managing the intersection of commercial brand launches and regulatory compliance to drive efficiency. Marissa Poli fosters collaboration between regional offices, ensuring that the firm's expertise is leveraged effectively across North America, Europe, and Asia. By streamlining operational processes, the President supports the delivery of transformative outcomes that accelerate medical access. This focus on organizational excellence allows the company to maintain its competitive edge while scaling its impact on the global life sciences market.

Stephen Weisman, the Global President at Lumanity, directs the firm's international expansion and market penetration strategies across more than 50 countries. By overseeing operations in the United Kingdom, Europe, and Asia, Weisman ensures that the company provides consistent, high-value support to global pharmaceutical and biotech organizations. The Global President manages the integration of regional insights into a unified service model, allowing for the successful execution of complex commercialization projects. This leadership role involves coordinating with local teams to navigate diverse regulatory environments and payer landscapes. Stephen Weisman drives the implementation of global standards for evidence generation, which enables clients to demonstrate product value on a worldwide scale. By fostering international partnerships, the Global President secures the firm's influence in the global healthcare ecosystem. This strategic oversight ensures that the company remains at the forefront of medical innovation, consistently delivering results that empower patients and providers everywhere.

Christopher Evans, the President Patient-Centered Outcomes at Lumanity, directs the research and analysis of real-world evidence to ensure medical products meet the specific needs of patients. By focusing on patient-centric data, Evans enables pharmaceutical clients to generate the evidence required to demonstrate product value to payers and regulators. The President Patient-Centered Outcomes oversees the design of studies that capture the patient experience, translating these findings into actionable insights for commercial success. This leadership role involves collaborating with clinical and regulatory teams to ensure that patient outcomes remain a central component of the product development lifecycle. Christopher Evans drives the development of methodologies that quantify the impact of medical advances on quality of life. By prioritizing the patient perspective, the President Patient-Centered Outcomes helps clients secure market access and achieve sustainable success. This focus on evidence-based outcomes directly supports the company's mission to optimize access to life-changing medical treatments.

Juliet Munakata, the Global President, HEOR at Lumanity, directs the health economics and outcomes research division to establish the economic value of medical innovations. By analyzing cost-effectiveness and clinical outcomes, Munakata provides pharmaceutical and biotech companies with the data necessary for successful payer submissions and reimbursement negotiations. The Global President, HEOR oversees the development of robust economic models that support product positioning in competitive markets. This leadership role involves managing complex research projects that bridge the gap between clinical data and real-world economic impact. Juliet Munakata drives the integration of HEOR insights into the broader commercialization strategy, ensuring that products are priced to reflect their true value to the healthcare system. By leading this critical function, the Global President, HEOR enables clients to navigate the complexities of global health systems. This work ensures that medical advances reach patients by providing the evidence required for sustainable market access and long-term success.

Robert Budreau, the President & Producer at Lumanity, directs the creative production and media strategy for high-impact product campaigns and commercial launches. By leveraging visual and narrative storytelling, Budreau transforms complex scientific data into engaging content that resonates with key stakeholders. The President & Producer oversees the production of multimedia assets that support brand positioning and market education. This leadership role involves managing the creative process from concept to execution, ensuring that all materials align with the firm's strategic goals and regulatory requirements. Robert Budreau drives the development of innovative campaigns that highlight the value of medical products to providers and patients. By integrating creative production with commercial strategy, the President & Producer enhances the firm's ability to deliver compelling narratives that drive market adoption. This focus on high-quality production ensures that the company's insights are communicated effectively, supporting the overall mission of accelerating access to medical advances.